CD8A and melanoma: In a human phase II study in pre-treated melanoma patients, tadalafil (a PDE-5 inhibitor) induced stable disease in 3/12 patients, who showed higher numbers of CD8 and TILs in their metastases and both CD4 and CD8 cells in their peripheral blood, increased CD3ζ-chain expression.